Reinventing depression treatment via transcranial magnetic brain stimulation (TMS)

Conclusions: SAINT, an accelerated, high-dose, iTBS protocol with fcMRI-guided targeting, was well tolerated and safe. Double-blinded sham-controlled trials are needed to confirm the remission rate observed in this initial study. The Study in Context: Machine-learning study finds EEG brain signatures that predict response to antidepressant treatments Should Cognitive Behavioural Therapy (not antidepressant drugs) be the first-line treatment for depression? Neuroengineering meets neuroethics to address treatment-resistant depression CVS Health: Cognitive behavioral therapy (CBT) apps may help you more than sleeping pills A call to action: We need the right incentives to guide ethical innovation in neurotech and healthcare New report: Empowering 8 Billion Minds via Ethical Development and Adoption of Neurotechnologies 10 highlights from the 2019 SharpBrains Virtual Summit ? Rethinking and Retooling Brain Health and Mental Health from SharpBrains
Source: SharpBrains - Category: Neuroscience Authors: Tags: Cognitive Neuroscience Health & Wellness Technology antidepressant treatments brain stimulation cognitive side effects depression magnetic brain stimulation neurological disorders noninvasive brain stimulation noninvasive neurotechnolo Source Type: blogs